The biotech sciences include genetics, genetic engineering, gene therapy, applied immunology, and bioengineering. Companies that break ground in these areas may profit handsomely. Those that do ...

As a result, before I move on to my list of the four most promising pharmaceutical companies in the global immunology market, I would like to once again ask you to pay attention to my approach to ...

Just a few months after raising $200 million in third-round financing, immunology specialist Zenas ... acceleration in the number of biotech companies seeking public listings after a two-year ...

China is teeming with promising science in areas such as oncology and immunology ... comes not only from other VC firms or even biotech companies. It’s coming from big pharma, he said.

This is not about doing it all but about translating external trends into actionable strategies that keep companies ... the future of biotech The convergence of oncology and immunology is not ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

Biotech Fluidics reports that a major pharmaceutical customer has purchased 17 SPR-200 solvent recycler units to improve sustainable use of solvents by HPLC systems in their analytical laboratories.

About Zenas BioPharma, Inc. Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based ...